Home
R StocksTrader Stocks Live Prices
Ohr Pharmaceutical Inc.

Ohr Pharmaceutical Inc.

Available to platforms

Ohr Pharmaceutical Inc. (Ticker: OHRP) was a biotechnology company focused on developing therapies for ophthalmic diseases, including macular degeneration and other retinal conditions. Its lead product candidate, squalamine, was investigated as a treatment for wet age-related macular degeneration. Following disappointing clinical trial results, the company shifted strategies and merged with NeuBase Therapeutics in 2019, pivoting to the development of genetic medicine therapies.

Ohr Pharmaceutical Inc. - OHRP stocks live chart

Analyze price movements of Ohr Pharmaceutical Inc. online with R StocksTrader’s advanced stock charts. There's no need to manually refresh the chart as quotes are updated automatically in real-time. View both the current and previous OHRP quotes – including the latest bid at 24.9 USD and ask at 28.7 USD – and get all the necessary information for adding Ohr Pharmaceutical Inc. to your investment portfolio.

With R StocksTrader, you can invest in Ohr Pharmaceutical Inc. and explore real stocks and CFDs on other prominent American and European companies. Stocks, Indices, Metals – over 12,000 assets are available for trading on our web terminal. Explore the dynamic price movements of popular assets, like Ohr Pharmaceutical Inc., and expand your trading opportunities by investing in new instruments in 2025.

Risk Warning: Past performance of OHRP does not predict future returns.

FAQ

Open a trading account at RoboForex, decide on the number of assets to buy and then place an order for Ohr Pharmaceutical Inc. (OHRP).

You can trade Ohr Pharmaceutical Inc. (OHRP) on the R StocksTrader platform.

You can trade online Ohr Pharmaceutical Inc. (OHRP) on Prime, ECN, Pro, or R StocksTrader accounts.

All financial charts